Introduction

Corona Remedies Limited, a well-established pharmaceutical company based in Ahmedabad, is set to enter the capital markets. Having carved a niche over two decades in women's health, heart care, pain relief, and more, the company is now aiming to fund its growth ambitions and expand its footprint with this IPO.

Corona Remedies IPO Details

• IPO Opening Date: December 8, 2025
• IPO Closing Date: December 10, 2025
• Price Band: ₹1008 to ₹1062 per share
• Minimum Lot Size: 14 Shares
• Total Issue Size :- 61,71,101 shares
  (aggregating up to ₹655.37 Cr)
• Allotment Date :- December 11, 2025
• Listing Date :- Dec 15, 2025
• Cut-off time for UPI mandate confirmation :- 5 PM on Wed, Dec 10, 2025
• Lead Managers: JM Financial Ltd., IIFL Capital Services Ltd., Kotak Mahindra Capital Co. Ltd.
• Registrar: Bigshare Services Pvt. Ltd.

Business Overview

Founded in 2004, Corona Remedies has grown into one of the leading players in the Indian pharmaceutical market, especially in select therapeutic areas such as women’s healthcare, cardio-diabeto, pain management, urology, and multispecialty pharmaceuticals. The company boasts 67 brands and pan-India presence with over 2,500 medical representatives covering 22 states.

Financial Snapshot

Corona Remedies Ltd.'s revenue increased by 18% and profit after tax (PAT) rose by 65% between the financial year ending with March 31, 2025 and March 31, 2024.

Period Ended	30 Jun 2025	31 Mar 2025	31 Mar 2024	31 Mar 2023
Assets	1,012.38	929.86	830.58	595.02
Total Income	348.56	1,202.35	1,020.93	891.10
Profit After Tax	46.20	149.43	90.50	84.93
EBITDA	71.80	245.91	161.19	135.03
NET Worth	607.02	606.34	480.41	408.52
Reserves and Surplus	545.86	545.18	419.25	347.36
Total Borrowing	106.65	62.70	134.14	2.33
Amount in ₹ Crore

Key Performance Indicator (KPI)

KPI	Values
ROE	27.50%
ROCE	41.32%
Debt/Equity	0.10
RoNW	24.65%
PAT Margin	12.49%
EBITDA Margin	20.55%
Price to Book Value	10.71
Market Capitalization	₹6,495.20 Cr.

IPO Lot Size :-

Investors can bid for a minimum of 14 shares and in multiples thereof.  The following table depicts the minimum and maximum investment by Individual Investors (Retail) and HNI in terms of shares and amount.

IPO Reservation :-

Investor Category	Shares Offered
QIB Shares Offered	Not less than 50% of the Net Offer
Retail Shares Offered	Not more than 35% of the Net Offer
NII Shares Offered	Not more than 15% of the Net Offer

Key Strengths:-

• Rich experience with over 20 years of operations in the pharma sector
• Strong portfolio spanning diverse therapeutic areas with 67 brands
• Pan-India reach with extensive sales and marketing network
• Solid financial track record and improving profitability
• Zero or low debt providing financial stability

Key Risks:-

• Intense Competition: The pharmaceutical industry
• Regulatory Risks
• Product Concentration only to certain product segment
• Raw Material Price Volatility
• Dependency on Third-party Manufacturing and Distribution
• Litigation and Intellectual Property Risks

How To Apply for the Online?

• Login or Open demat account with JM Financial Services / JM PRO app: Open the JM PRO app or JM Financial Services website and log in with your credentials. 
• Locate the IPO Section: Navigate to the 'IPO' section on the platform. 
• Select IPO: Find and select the IPO from the list of open IPOs. 
• Enter the Lot Size: Specify the number of lots you want to bid for. 
• Submit Your UPI ID: Enter your UPI ID to link your payment method and submit your application. 
• Approve Funds: Once you receive the bid request on your UPI app, approve it by entering your UPI PIN. 

How To Check the Allotment Status of IPO?

Steps to check IPO allotment status on JM Pro app: 

• Log in to the JM Pro app. 
• Go to the IPO Section and then to IPO Orders. 
• Select the individual IPO that you had applied for and check the allotment status. 

JM Financial Services will notify you of your IPO allotment status via push notification and email

Final Thoughts :-

Corona Remedies’ IPO offers a solid, steady investment opportunity in India’s growing pharmaceutical landscape with a trusted brand and solid fundamentals. Potential investors should look out for official IPO dates and price details to evaluate further.

FAQs:-

Q: What is the expected price band of the Corona Remedies IPO?
A: The official price band will be announced before the subscription window opens.

Q: When will the Corona Remedies IPO open and close?
A: The IPO dates are expected soon; typically lasts about 3–5 days.

Q: What is the minimum lot size and investment?
A: The lot size and minimum investment details will be available in the official prospectus at IPO launch.

Q: Who are the lead managers of the IPO?
A: JM Financial Ltd., IIFL Capital Services Ltd., and Kotak Mahindra Capital Co. Ltd. are the lead managers.

Q: How strong is Corona Remedies financially?
A: The company has shown steady revenue growth and profitability with a strong ROE and minimal debt.